← SynDRA
SANGIVAMYCIN
SynDRA canonical compound SYN0003852 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Mechanism of action | DNA inhibitor |
Mechanisms of action (all sources)
Drug classes
- Anti-Bacterial Agents
- Antibiotics, Antineoplastic
Cross-references
Synonyms
- 7-Deazaadenosine-7-carboxamide
- L8YQ8Z3T9T
- 7-Deaza-7-carbamoyladenosine
- Antibiotic B-14437
- CHEMBL101892
- CHEBI:85997
- NSC-65346
- 4-amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide
- 4-Amino-7-beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine-5-carboxamide
- B-14437
- 4-amino-7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide
- 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-7-.beta.-D-ribofuranosyl-
- BRN 0626355
- Sanzivamycin
- Sangivamycin, hydrochloride
- 3nyn
- 7H-Pyrrolo(2,3-d)pyrimidine-5-carboxamide, 4-amino-7-.beta.-D-ribofuranosyl-
- SGV
- UNII-L8YQ8Z3T9T
- cid_5153
- BIDD:GT0419
- SCHEMBL195540
- 4-Amino-7-.beta.-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine-5-carboxamide
- DTXSID601028118
- ZINC4217438
- BDBM50049820
- 7H-Pyrrolo(2,3-d)pyrimidine-5-carboxamide, 4-amino-7-beta-D-ribofuranosyl-
- 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboxamide
- BA-90912
- HY-118384
- CS-0065802
- J-011802
- Q27158840
- 4-Amino-5-carboxamide-7-(D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine
- 4-amino-7-(beta-d-ribofuranosyl)-7h-pyrrolo[2,3-d]pyrimidine-5-carboxamide
- 4-amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide
- 4-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid amide
- 4-Amino-7-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid amide
Look up SANGIVAMYCIN in the interactive SynDRA portal →